Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation
(UNCOVER-AF Trial)
Recruiting at11 trial locations
SW
Overseen byStephan Willems, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Acutus Medical
No Placebo Group
Trial Summary
What is the purpose of this trial?
A prospective, single-arm, multi-center, multi-national, non-randomized, post-market study designed to provide clinical data regarding the use of the AcQMap™ System in the ablation of persistent atrial fibrillation. (CL-AF-002 - EU) A prospective, single-arm, multi-center, multi-national non-randomized study designed to provide clinical data regarding the use of the AcQMap™ System in the ablation of persistent atrial fibrillation. (CL-AF-001 - Canadian)
Research Team
SW
Stephan Willems, MD
Principal Investigator
Universitätsklinikum Hamburg-Eppendorf (UKE)
Eligibility Criteria
Inclusion Criteria
Scheduled for an ablation of persistent atrial fibrillation
Treatment Details
Interventions
- AcQMap System (Procedure)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: AcQMap SystemExperimental Treatment1 Intervention
All patients who underwent catheter ablation using the AcQMap System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Acutus Medical
Lead Sponsor
Trials
17
Recruited
2,000+